XML 18 R5.htm IDEA: XBRL DOCUMENT v3.20.2
Consolidated Statements of Changes in Stockholders' Equity Statement - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-in Capital
Retained Earnings
Accumulated Other Comprehensive Income
Noncontrolling Interest [Member]
Cumulative Effect, Period of Adoption, Adjustment
Cumulative Effect, Period of Adoption, Adjustment
Retained Earnings
Beginning balance at Dec. 31, 2018 $ 889,312 $ 28 $ 495,366 $ 393,918 $ 0 $ 0 $ 97 $ 97
Beginning balance (in shares) at Dec. 31, 2018   28,404,316            
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income 5,873     5,873   0    
Share-based compensation 870   886 (16)        
Issuance of restricted and deferred stock units (132)   (132)          
Issuance of restricted and deferred stock units (in shares)   14,312            
Employee stock purchase plan 811   811          
Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs (10)   (10)          
Employee stock purchase plan (in shares)   15,932            
Dividends paid (8,528)     (8,528)        
Ending balance at Mar. 31, 2019 888,293 $ 28 496,921 391,344 0 0    
Ending balance (in shares) at Mar. 31, 2019   28,434,560            
Beginning balance at Dec. 31, 2018 889,312 $ 28 495,366 393,918 0 0 $ 97 $ 97
Beginning balance (in shares) at Dec. 31, 2018   28,404,316            
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income 29,113              
Ending balance at Sep. 30, 2019 896,664 $ 28 499,377 397,259 0 0    
Ending balance (in shares) at Sep. 30, 2019   28,456,490            
Beginning balance at Mar. 31, 2019 888,293 $ 28 496,921 391,344 0 0    
Beginning balance (in shares) at Mar. 31, 2019   28,434,560            
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income 13,762     13,538   224    
Distribution to noncontrolling interest (224)         (224)    
Share-based compensation 702   718 (16)        
Issuance of restricted and deferred stock units (6)   (6)          
Issuance of restricted and deferred stock units (in shares)   7,579            
Dividends paid (8,532)     (8,532)        
Ending balance at Jun. 30, 2019 893,995 $ 28 497,633 396,334 0 0    
Ending balance (in shares) at Jun. 30, 2019   28,442,139            
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income 9,478     9,478        
Share-based compensation 936   952 (16)        
Employee stock purchase plan 792   792          
Employee stock purchase plan (in shares)   14,351            
Dividends paid (8,537)     (8,537)        
Ending balance at Sep. 30, 2019 896,664 $ 28 499,377 397,259 0 0    
Ending balance (in shares) at Sep. 30, 2019   28,456,490            
Beginning balance at Dec. 31, 2019 $ 889,984 $ 28 506,639 383,191 126 0    
Beginning balance (in shares) at Dec. 31, 2019 28,456,508 28,456,508            
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income $ 2,417     2,417        
Unrealized Gain (Loss) on Investments (135)       (135)      
Share-based compensation 208   251 (43)        
Issuance of restricted and deferred stock units (785)   (785)          
Issuance of restricted and deferred stock units (in shares)   25,781            
Employee stock purchase plan 970   970          
Employee stock purchase plan (in shares)   15,552            
Dividends paid (9,118)     (9,118)        
Ending balance at Mar. 31, 2020 883,541 $ 28 507,075 376,447 (9) 0    
Ending balance (in shares) at Mar. 31, 2020   28,497,841            
Beginning balance at Dec. 31, 2019 $ 889,984 $ 28 506,639 383,191 126 0    
Beginning balance (in shares) at Dec. 31, 2019 28,456,508 28,456,508            
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income $ 48,231              
Ending balance at Sep. 30, 2020 $ 913,061 $ 29 509,031 403,923 78 0    
Ending balance (in shares) at Sep. 30, 2020 28,552,177 28,552,177            
Beginning balance at Mar. 31, 2020 $ 883,541 $ 28 507,075 376,447 (9) 0    
Beginning balance (in shares) at Mar. 31, 2020   28,497,841            
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income 19,721     19,721   0    
Unrealized Gain (Loss) on Investments 10       10      
Share-based compensation 966   1,009 (43)        
Issuance of restricted and deferred stock units 15 $ 1 14          
Issuance of restricted and deferred stock units (in shares)   18,864            
Dividends paid (9,122)     (9,122)        
Ending balance at Jun. 30, 2020 895,131 $ 29 508,098 387,003 1 0    
Ending balance (in shares) at Jun. 30, 2020   28,516,705            
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income 26,093     26,093        
Unrealized Gain (Loss) on Investments 77       77      
Share-based compensation 1,016   1,058 (42)        
Issuance of restricted and deferred stock units (985) $ 0 (985)          
Issuance of restricted and deferred stock units (in shares)   19,274            
Employee stock purchase plan 860   860          
Employee stock purchase plan (in shares)   16,198            
Dividends paid (9,131)     (9,131)        
Ending balance at Sep. 30, 2020 $ 913,061 $ 29 $ 509,031 $ 403,923 $ 78 $ 0    
Ending balance (in shares) at Sep. 30, 2020 28,552,177 28,552,177